Ackman defends Valeant, hints at more changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/3/2026
- Wall Street ends lower as Middle East tensions escalate
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Broadcom's sales and AI chip forecast comes in below expectations, shares tumble
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Oil gains as Middle East hostilities flare
- Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
- Navitas showcases 800V power delivery board at NVIDIA MGX ecosystem event
- Inotiv files for bankruptcy with $65 million financing commitment
- Alphabet plans $80 billion equity raise to fund AI infrastructure expansion, Berkshire Hathaway to invest $10 billion
- Alphabet plans $80 billion raise for AI, backed by Buffett’s Berkshire
- After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,
- After-Hours Stock Movers: PANW, CRWD, ZS, GTLB, ULTA
- After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
- After-Hours Stock Movers: DELL, MDB, AEO, NTAP, GAP, S, ADSK
- After-Hours Stock Movers: CRM, MRVL, SNOW, HPQ, DDOG, MDB, P, SNPS, BRZE, NCNO
Valeant Pharma (VRX) Continues Push Higher
May 3, 2016 12:44 PM EDTValeant Pharma (NYSE: VRX) is pushing to the highs of the session following positive credit rating agency comments on a default, strong results from peer Mallinckrodt, short covering and as Joe Papa officially assumes the reigns.
Shares are up 9.85% to $35.87.
... MoreGeneral Growth Properties (GGP) Declares $0.19 Quarterly Dividend; 2.7% Yield
May 3, 2016 8:50 AM EDTGeneral Growth Properties (NYSE: GGP) declared a quarterly dividend of $0.19 per share, or $0.76 annualized.
The dividend will be payable on July 29, 2016, to stockholders of record on July 15, 2016, with an ex-dividend date of July 13, 2016.
The annual yield on the dividend is 2.7... More
Valeant Pharma (VRX) Says Joseph Papa Officially Assumes Role of Chairman, CEO
May 3, 2016 7:15 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that Joseph C. Papa has assumed the role of Chairman and Chief Executive Officer. As previously announced, Joseph C. Papa succeeds J. Michael Pearson.
"I am thrilled to begin working closely with the talented... More
Valeant Pharma (VRX) may change its name at some point - Bill Ackman
May 2, 2016 12:43 PM EDTValeant Pharma (NYSE: VRX) may change its name at some point - Bill Ackman
... More